Exelixis
EXEL
#1639
Rank
HK$79.86 B
Marketcap
HK$285.34
Share price
-0.24%
Change (1 day)
58.10%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company